Product Information
Registration Status: ActivePIQRAY 250MG DAILY DOSE PACK (200mg + 50mg) is approved to be sold in Singapore with effective from 2020-03-25. It is marketed by NOVARTIS (SINGAPORE) PTE LTD, with the registration number of SIN15916P.
This product contains Alpelisib 200mg, and Alpelisib 200mg, and in the form of TABLET, FILM COATED. It is approved for ORAL use.
This product is manufactured by NOVARTIS PHARMA STEIN AG in SWITZERLAND,LEK PHARMACEUTICALS D.D. (Ljubljana) (Primary and Secondary packager) in SLOVENIA, andLEK PHARMACEUTICALS D.D. (Ljubljana) (Primary and Secondary packager) in SLOVENIA, and.
It is a Prescription Only Medicine that can only be obtained from a doctor or a dentist, or a pharmacist with a prescription from a Singapore-registered doctor or dentist.
Description
Alpelisib has been used in trials studying the treatment and basic science of Neoplasms, Solid Tumors, BREAST CANCER, 3rd Line GIST, and Rectal Cancer, among others.
Active Ingredient/Synonyms
Alpelisib | Alpelisib |
Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.
Description
Alpelisib has been used in trials studying the treatment and basic science of Neoplasms, Solid Tumors, BREAST CANCER, 3rd Line GIST, and Rectal Cancer, among others.
Active Ingredient/Synonyms
Alpelisib | Alpelisib |
Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.